Clinical Trial Update: Model-informed Dose Optimization for Rivaroxaban in Children With Giant Coronary Artery Aneurysm After Kawasaki Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing model-informed dose optimization of rivaroxaban in children with Kawasaki Disease who develop giant coronary artery aneurysms; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Aneurysm
• Kawasaki Disease

Drugs mentioned

• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Children's Hospital of Fudan University | Conditions: Kawasaki Disease, Pilot Study | Phase 4 | Status: RECRUITING